Antidepressant-induced hepatotoxicity

Alternative projections of mortality and disability by cause 1990–2020: Global Burden of Disease Study

Murray, C. J. L., & López, A. D. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07492-2 · Cited by 7,007 · see citing works

Drug-induced hepatotoxicity

Lee, W. M. (2003) · New England Journal of Medicine · doi:10.1056/nejmra021844 · Cited by 1,594 · see citing works

Criteria of drug-induced liver disorders

(1990) · Journal of Hepatology · doi:10.1016/0168-8278(90)90124-a · Cited by 1,106 · see citing works

Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability

Anderson, I. M. (2000) · Journal of Affective Disorders · doi:10.1016/s0165-0327(99)00092-0 · Cited by 940 · see citing works

Pharmacokinetic-Pharmacodynamic Consequences and Clinical Relevance of Cytochrome P450 3A4 Inhibition

Dresser, G. K., Spence, J. D., & Bailey, D. G. (2000) · Clinical Pharmacokinetics · doi:10.2165/00003088-200038010-00003 · Cited by 908 · see citing works

Potential Role of Pharmacogenomics in Reducing Adverse Drug Reactions

Phillips, K. A., Veenstra, D. L., Oren, E., Lee, J. K., & Sadée, W. (2001) · JAMA · doi:10.1001/jama.286.18.2270 · Cited by 705 · see citing works

Screening for Depression: Recommendations and Rationale

U.S. Preventive Services Task Force* (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-136-10-200205210-00012 · Cited by 524 · see citing works

Acetaminophen (paracetamol) hepatotoxicity with regular intake of alcohol: Analysis of instances of therapeutic misadventure

Zimmerman, H. J., & Maddrey, W. C. (1995) · Hepatology · doi:10.1002/hep.1840220312 · Cited by 458 · see citing works

Selective Serotonin Reuptake Inhibitors and Cytochrome P-450 Mediated Drug-Drug Interactions: An Update

Hemeryck, A., & Belpaire, F. M. (2002) · Current Drug Metabolism · doi:10.2174/1389200023338017 · Cited by 370 · see citing works

Ischemic hepatitis: clinical presentation and pathogenesis

Seeto, R. K., Fenn, B., & Rockey, D. C. (2000) · The American Journal of Medicine · doi:10.1016/s0002-9343(00)00461-7 · Cited by 361 · see citing works

Selective serotonin reuptake inhibitors: a review of efficacy and tolerability in depression

Mace, S., & Taylor, D. M. (2000) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.1.5.917 · Cited by 315 · see citing works

Drug-Induced Hepatotoxicity

Lee, W. M. (1995) · New England Journal of Medicine · doi:10.1056/nejm199510263331706 · Cited by 305 · see citing works

Clinical pharmacology of imipramine and related antidepressant compounds.

KLERMAN, G. L., & Jo, C. (1967) · PubMed · Cited by 273 · see citing works

Comparison of Two Clinical Scales for Causality Assessment in Hepatotoxicity

Lucena, M. I., Camargo, R., Andrade, R. J., Pérez, C. J., & de la Cuesta, F. S. (2001) · Hepatology · doi:10.1053/jhep.2001.20645 · Cited by 256 · see citing works

Biochemical and Cellular Mechanisms of Toxic Liver Injury

Kaplowitz, N. (2002) · Seminars in Liver Disease · doi:10.1055/s-2002-30100 · Cited by 240 · see citing works

The Safety of Fluoxetine - An Update

Cooper, G. L. (1988) · The British Journal of Psychiatry · doi:10.1192/s000712500029733x · Cited by 229 · see citing works

Isoniazid and Iproniazid: Activation of Metabolites to Toxic Intermediates in Man and Rat

Nelson, S. D., Mitchell, J. R., Timbrell, J. A., Snodgrass, W. R., & Corcoran, G. B. (1976) · Science · doi:10.1126/science.7838 · Cited by 227 · see citing works

Drug-induced liver disease

Chitturi, S., & Farrell, G. C. (2000) · Current Treatment Options in Gastroenterology · doi:10.1007/s11938-000-0034-7 · Cited by 221 · see citing works

Pharmacology of antidepressants

Richelson, E. (2001) · Mayo Clinic Proceedings · doi:10.4065/76.5.511 · Cited by 210 · see citing works

A review of the common properties of drugs with idiosyncratic hepatotoxicity and the “multiple determinant hypothesis” for the manifestation of idiosyncratic drug toxicity

Li, A. P. (2002) · Chemico-Biological Interactions · doi:10.1016/s0009-2797(02)00051-0 · Cited by 181 · see citing works

Metabolism of the Newer Antidepressants

Caccia, S. (1998) · Clinical Pharmacokinetics · doi:10.2165/00003088-199834040-00002 · Cited by 175 · see citing works

A Comparison of Paroxetine, Imipramine and Placebo in Depressed Out-patients

Dunbar, G. C., Cohn, J. B., Fabre, L. F., Feighner, J. P., Fieve, R. R., MENDELS, J., & Shrivastava, R. K. (1991) · The British Journal of Psychiatry · doi:10.1192/bjp.159.3.394 · Cited by 172 · see citing works

Depressive illness

Doris, A. B., Ebmeier, K. P., & Shajahan, P. M. (1999) · The Lancet · doi:10.1016/s0140-6736(99)03121-9 · Cited by 138 · see citing works

Incidence of parenchymal liver diseases in Denmark, 1981 to 1985: analysis of hospitalization registry data. The Danish Association for the Study of the Liver.

Almdal, T., & Sørensen, T. I. A. (1991) · PubMed · Cited by 130 · see citing works

Plasma membrane cytochromes P450 as neoantigens and autoimmune targets in drug-induced hepatitis

Robin, M., Roy, M. L., Descatoire, V., & Pessayre, D. (1997) · Journal of Hepatology · doi:10.1016/s0168-8278(97)82329-x · Cited by 129 · see citing works

Fluoxetine treatment of depression caused by interferon-alpha.

Levenson, J. L., & Fallon, H. J. (1993) · PubMed · Cited by 126 · see citing works

Hepatotoxicity of Psychotropic Drugs

Selim, K., & Kaplowitz, N. (1999) · Hepatology · doi:10.1002/hep.510290535 · Cited by 119 · see citing works

Mechanisms of Hepatic Transport of Drugs: Implications for Cholestatic Drug Reactions

Bohan, A., & Boyer, J. L. (2002) · Seminars in Liver Disease · doi:10.1055/s-2002-30099 · Cited by 115 · see citing works

Clinical practice. Adolescent depression.

Brent, D., & Birmaher, B. (2002) · New England Journal of Medicine · doi:10.1056/nejmcp012249 · Cited by 114 · see citing works

Hepatotoxicity Associated With the New Antidepressants

García‐Pando, A. C., del Pozo, J. G., Sanchez, A., Martín, A. V., de Castro, A. M. R., & Lucena, M. I. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n0208 · Cited by 109 · see citing works

Nefazodone-Induced Liver Failure: Report of Three Cases

Aranda‐Michel, J., Koehler, A., Bejarano, P. A., Poulos, J., Luxon, B. A., Khan, C. M., Ee, L. C., Balistreri, W. F., & Weber, F. L. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-4-199902160-00013 · Cited by 102 · see citing works

Antecedent liver disease and drug toxicity

Schenker, S., Martin, R. R., & Hoyumpa, A. M. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80325-0 · Cited by 90 · see citing works

Moclobemide

Fulton, B., & Benfield, P. (1996) · Drugs · doi:10.2165/00003495-199652030-00013 · Cited by 86 · see citing works

Role of reactive metabolites in drug-induced hepatitis

Pessayre, D. (1995) · Journal of Hepatology · doi:10.1016/s0168-8278(21)80002-1 · Cited by 86 · see citing works

Risks and Benefits of Selective Serotonin Reuptake Inhibitors in the Treatment of Depression

Mourilhe, P. R., & Stokes, P. E. (1998) · Drug Safety · doi:10.2165/00002018-199818010-00005 · Cited by 80 · see citing works

Possible role of HLA in hepatotoxicity

Berson, A., Fréneaux, E., Larrey, D. G., Lepage, V., Douay, C., Mallet, C., Fromenty, B., Benhamou, J., & Pessayre, D. (1994) · Journal of Hepatology · doi:10.1016/s0168-8278(94)80004-9 · Cited by 79 · see citing works

An in vitro study of the microsomal metabolism and cellular toxicity of phenytoin, sorbinil and mianserin.

Riley, R., Maggs, J. L., Lambert, C., Kitteringham, N. R., & Park, B. K. (1988) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1988.tb05298.x · Cited by 79 · see citing works

Drug hepatotoxicity

Goodman, Z. D. (2002) · Clinics in Liver Disease · doi:10.1016/s1089-3261(02)00011-9 · Cited by 74 · see citing works

The rational use of potentially hepatotoxic medications in patients with underlying liver disease

Lewis, J. H. (2002) · Expert Opinion on Drug Safety · doi:10.1517/14740338.1.2.159 · Cited by 73 · see citing works

Fluoxetine disposition and elimination in cirrhosis

Schenker, S., Bergstrom, R. F., Wolen, R. L., & Lemberger, L. (1988) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1988.161 · Cited by 68 · see citing works

Tianeptine, a new tricyclic antidepressant metabolized by β-oxidation of its heptanoic side chain, inhibits the mitochondrial oxidation of medium and short chain fatty acids in mice

Fromenty, B., Fréneaux, E., Labbe, G., Deschamps, D., Larrey, D. G., Lettéron, P., & Pessayre, D. (1989) · Biochemical Pharmacology · doi:10.1016/0006-2952(89)90580-7 · Cited by 65 · see citing works

Hepatocellular Jaundice as a Complication of Iproniazid Therapy

Rosenblum, L. (1960) · Archives of Internal Medicine · doi:10.1001/archinte.1960.00270160081010 · Cited by 65 · see citing works

Changes in the pattern of antidepressant use upon the introduction of the new antidepressants: a prescription database study

Rosholm, J.-U., Gram, L. F., Isacsson, G., Hallas, J., & Bergman, U. (1997) · European Journal of Clinical Pharmacology · doi:10.1007/s002280050275 · Cited by 63 · see citing works

Tolerance after liver transplantation: does it exist and can immunosuppression be withdrawn?

Riordan, S. M., & Williams, R. L. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80326-2 · Cited by 63 · see citing works

Effect of bolus injection and continuous infusion of somatostatin on gastric perfusion in cirrhotic patients with portal-hypertensive gastropathy

Panés, J., Pique, J. M., Bordas, J. M., Casadevall, M., Terés, J., Bosch, J., & Rodés, J. (1994) · Hepatology · doi:10.1002/hep.1840200211 · Cited by 58 · see citing works

Trazodone-Induced Hepatotoxicity: A Case Report With Comments on Drug-Induced Hepatotoxicity

Fernandes, N. F., Martin, R. R., & Schenker, S. (2000) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2000.t01-1-01780.x · Cited by 57 · see citing works

Inhibition of Trazodone Metabolism by Thioridazine in Humans

Yasui, N., Otani, K., Kaneko, S., Ohkubo, T., Osanai, T., Ishida, M., Mihara, K., Kondo, T., Sugawara, K., & Fukushima, Y. (1995) · Therapeutic Drug Monitoring · doi:10.1097/00007691-199508000-00003 · Cited by 55 · see citing works

Acute Hepatitis Due to Fluoxetine Therapy

Cai, Q., Benson, M. A., Talbot, T. J., Devadas, G., Swanson, H. J., Olson, J. L., & Kirchner, J. P. (1999) · Mayo Clinic Proceedings · doi:10.4065/74.7.692 · Cited by 55 · see citing works

Acute liver injury associated with the use of ebrotidine, a new H 2 -receptor antagonist

Andrade, R. J., Lucena, M. I., Martín-Vivaldi, R., Fernández‐Santaella, M. C., Nogueras, F., Peláez, G. I. C., Gómez‐Outes, A., García-Escaño, M. D., Bellot, V., Hervás, A., et al. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80343-2 · Cited by 55 · see citing works

A new antimitochondria antibody (anti-M6) in iproniazid-induced hepatitis.

(1982) · PubMed Central · Cited by 53 · see citing works

Drug points: Paroxetine and hepatotoxicity

Benbow, S. J., & Gill, G. (1997) · BMJ · doi:10.1136/bmj.314.7091.1387a · Cited by 53 · see citing works

Prolonged cholestasis and progressive hepatic fibrosis following imipramine therapy

Horst, D. A., Grace, N. D., & LeCompte, P. M. (1980) · Gastroenterology · doi:10.1016/0016-5085(80)90383-2 · Cited by 52 · see citing works

Toxicity of tricyclic antidepressants to isolated rat hepatocytes

Abernathy, C. O., Lukacs, L. G., & Zimmerman, H. J. (1975) · Biochemical Pharmacology · doi:10.1016/0006-2952(75)90216-6 · Cited by 52 · see citing works

Paroxetine for the Prevention of Depression Induced by Interferon Alfa

Hickerson, K. A. (2001) · New England Journal of Medicine · doi:10.1056/nejm200108023450514 · Cited by 52 · see citing works

Paroxetine for the prevention of depression induced by interferon alfa.

Mr, K., Schäfer, A., & Scheurlen, M. (2001) · PubMed · Cited by 50 · see citing works

Genetic predisposition to drug hepatotoxicity: Role in hepatitis caused by amineptine, a tricyclic antidepressant

Larrey, D. G., Berson, A., Habersetzer, F., Tinel, M., Castot, A., Babany, G., Lettéron, P., Fréneaux, E., Loeper, J., Dansette, P. M., et al. (1989) · Hepatology · doi:10.1002/hep.1840100208 · Cited by 45 · see citing works

A double-blind study of alprazolam and lorazepam in the treatment of anxiety.

Ruiz, A. S. (1983) · PubMed · Cited by 43 · see citing works

Lethal Hepatic Necrosis After Therapy With Imipramine and Desipramine

Powell, W. J. (1968) · JAMA · doi:10.1001/jama.1968.03150030098027 · Cited by 43 · see citing works

Venlaxafine-Associated Hepatitis

Horsmans, Y., Clercq, M. D., & Sempoux, C. L. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-130-11-199906010-00014 · Cited by 42 · see citing works

Acute Hepatic Necrosis Following Treatment with Amitriptyline and Diazepam

Cunningham, M. L. (1965) · The British Journal of Psychiatry · doi:10.1192/bjp.111.480.1107 · Cited by 39 · see citing works

Letters of condolence.

Hyla, J. F. (2001) · PubMed · Cited by 39 · see citing works

Case Report: Acute Liver Failure After Treatment with Nefazodone

Lucena, M. I., Andrade, R. J., Gómez‐Outes, A., Rubio, M., & Cabello, M. R. (1999) · Digestive Diseases and Sciences · doi:10.1023/a:1026620029470 · Cited by 38 · see citing works

Chronic hepatitis related to use of fluoxetine.

Johnston, D. E., & Wheeler, D. E. (1997) · PubMed · Cited by 38 · see citing works

New antidepressants: use in high-risk patients.

Hale, A. S. (1993) · PubMed · Cited by 38 · see citing works

Venlafaxine-Associated Hepatitis

Cardona, X., Ávila, A., & Castellanos, P. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-132-5-200003070-00016 · Cited by 37 · see citing works

[Evolution of antidepressive drug consumption in Spain. The impact of selective serotonin re-uptake inhibitors].

Alonso, P., de Abajo, F. J., Martínez, J. J., Montero, D., Martín-Serrano, G., & Madurga, M. (1997) · PubMed · Cited by 37 · see citing works

Case Report: Chronic Liver Injury Related to Use of Bentazepam

Andrade, R. J., Lucena, M. I., Aguilar, J. M. V., Lazo, M., Camargo, R., Moreno, P., García-Escaño, M. D., Márquez, A., Alcántara, R., & Alcaín, G. (2000) · Digestive Diseases and Sciences · doi:10.1023/a:1005520523502 · Cited by 37 · see citing works

Drug PointsFatal hepatic necrosis associated with trazodone and neuroleptic drugsRhabdomyolysis induced by thioridazine

Nankivell, B. J., Bhandari, P., & Koller, L. J. (1994) · BMJ · doi:10.1136/bmj.309.6951.378 · Cited by 35 · see citing works

Trazodone and Liver Toxicity

CHU, A. G., GUNSOLLY, B. L., SUMMERS, R. W., ALEXANDER, B., MCCHESNEY, C., & TANNA, V. L. (1983) · Annals of Internal Medicine · doi:10.7326/0003-4819-99-1-128_3 · Cited by 35 · see citing works

Symptomatic liver injury probably related to sertraline.

Hautekèete, M., Colle, I. O., Vlierberghe, H. V., & Elewaut, A. (1998) · PubMed · Cited by 34 · see citing works

Treatment of Depression Following Acute Myocardial Infarction

Carney, R. M. (2002) · JAMA · doi:10.1001/jama.288.6.750 · Cited by 34 · see citing works

Hepatitis Caused by Amitriptyline Therapy

YON, J. L. (1975) · JAMA · doi:10.1001/jama.1975.03250080035013 · Cited by 34 · see citing works

Cross hepatotoxicity between tricyclic antidepressants.

Larrey, D. G., RUEFF, B., Pessayre, D., Danan, G., Algard, M., Genève, J., & Benhamou, J. P. (1986) · Gut · doi:10.1136/gut.27.6.726 · Cited by 34 · see citing works

Fluoxetine-induced hepatitis: why is postmarketing surveillance needed?

Capellà, D., Bruguera, M., Figueras, A., & Laporte, J. (1999) · European Journal of Clinical Pharmacology · doi:10.1007/s002280050671 · Cited by 32 · see citing works

Tianeptine — an instance of drug-induced hepatotoxicity predicted by prospective experimental studies

Bricquir, Y. L., Larrey, D. G., Blanc, P., Pageaux, G., & Michel, H. (1994) · Journal of Hepatology · doi:10.1016/s0168-8278(94)80237-8 · Cited by 32 · see citing works

CASE REPORT: Acute Hepatitis Induced by Bupropion

Hu, K., Tiyyagura, L., Kanel, G. C., & Redeker, A. G. (2000) · Digestive Diseases and Sciences · doi:10.1023/a:1005553405313 · Cited by 32 · see citing works

Trazodone-induced hepatotoxicity and leukonychia

Longstreth, G. F., & Hershman, J. (1985) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(85)80328-5 · Cited by 31 · see citing works

Hepatic injury caused by mianserin.

Otani, K., Kaneko, S., Tasaki, H., & Fukushima, Y. (1989) · BMJ · doi:10.1136/bmj.299.6697.519-a · Cited by 30 · see citing works

Hepatitis secondary to fluoxetine treatment

Friedenberg, F. K., & Rothstein, K. D. (1996) · American Journal of Psychiatry · doi:10.1176/ajp.153.4.580a · Cited by 30 · see citing works

Case Report: Reversible Nefazodone-Induced Liver Failure

Eloubeidi, M. A., Gaede, J. T., & Swaim, M. W. (2000) · Digestive Diseases and Sciences · doi:10.1023/a:1005558015787 · Cited by 29 · see citing works

Acute cholestatic hepatitis induced by bupropion prescribed as pharmacological support to stop smoking. A case report

Alvaro, D., Muda, A. O., Moscatelli, R., & Attili, A. F. (2001) · Digestive and Liver Disease · doi:10.1016/s1590-8658(01)80049-9 · Cited by 27 · see citing works

Severe hepatotoxicity with jaundice associated with paroxetine

Odeh, M., Misselevech, I., Boss, J. H., & Oliven, A. (2001) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2001.04060.x · Cited by 26 · see citing works

Chronic Active Hepatitis Associated with Trazodone Therapy

Beck, P. L., Bridges, R. J., Demetrick, D. J., Kelly, J. K., & Lee, S. S. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-118-10-199305150-00006 · Cited by 26 · see citing works

Metabolic activation of the new tricyclic antidepressant tianeptine by human liver cytochrome P450

Larrey, D. G., Tinel, M., Lettéron, P., Maurel, P., Loeper, J., Belghiti, J., & Pessayre, D. (1990) · Biochemical Pharmacology · doi:10.1016/0006-2952(90)90554-x · Cited by 26 · see citing works

Bentazepam-associated chronic liver disease

Andrade, R. J., Lucena, M. I., Alcántara, R., & Fraile, J. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92065-6 · Cited by 26 · see citing works

Trazodone and Intrahepatic Cholestasis

Sheikh, K. H., & NIES, A. S. (1983) · Annals of Internal Medicine · doi:10.7326/0003-4819-99-4-572_1 · Cited by 25 · see citing works

Severe liver injury due to phenelzine with unique hepatic deposition of extracellular material

Bonkovsky, H. L., Blanchette, P. L., & Schned, A. R. (1986) · The American Journal of Medicine · doi:10.1016/0002-9343(86)90826-0 · Cited by 25 · see citing works

Jaundice Associated with Amitriptyline

Morgan, D. H. (1969) · The British Journal of Psychiatry · doi:10.1192/bjp.115.518.105 · Cited by 25 · see citing works

Cross hepatotoxicity between tricyclic antidepressants and phenothiazines.

Rémy, A.-J., Larrey, D. G., Pageaux, G., Ribstein, J., Ramos, J., & Michel, H. (1995) · PubMed · Cited by 23 · see citing works

Reversible Hepatotoxicity of Paroxetine in a Patient with Major Depression

Helmchen, C., Boerner, R. J., Meyendorf, R., & Hegerl, U. (1996) · Pharmacopsychiatry · doi:10.1055/s-2007-979576 · Cited by 23 · see citing works

Amitriptyline-Induced Fulminant Hepatitis

Danan, G., Bernuau, J., Moullot, X., Degott, C., & Pessayre, D. (2009) · Digestion · doi:10.1159/000199103 · Cited by 23 · see citing works

Liver Injury Associated With Tranylcypromine Therapy

Bandt, C., & Hoffbauer, F. W. (1964) · JAMA · doi:10.1001/jama.1964.03060340050015 · Cited by 21 · see citing works

HEPATOTOXICITY OF ANESTHETICS AND OTHER CENTRAL NERVOUS SYSTEM DRUGS

Holt, C., CSETE, M. E., & Martin, P. B. (1995) · Gastroenterology Clinics of North America · doi:10.1016/s0889-8553(21)00231-4 · Cited by 21 · see citing works

Phenelzine-Induced Fulminant Hepatic Failure

Gómez‐Gil, E., Salmeron, J. M., & Mas, A. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-124-7-199604010-00014 · Cited by 20 · see citing works

The Rise of Serum Aminotransferases in a Patient Treated with Bupropion

Oslin, D. W., & Duffy, K. (1993) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199310000-00015 · Cited by 20 · see citing works

A call for papers

Aaron, K. F. (2002) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.2002.11133.x · Cited by 20 · see citing works

CASE REPORT: Hepatotoxicity in Patients with Cirrhosis, an Often Unrecognized Problem

Andrade, R. J., Lucena, M. I., Fernández, C., Vega, J. L., & Camargo, R. (2001) · Digestive Diseases and Sciences · doi:10.1023/a:1010627518254 · Cited by 20 · see citing works

Acute cholestasis by fluoxetine.

Cosme, Á., Barrio, J., Lobo, C., Gil, I., Castiella, A., & Arenas, J. I. (1996) · PubMed · Cited by 19 · see citing works

Hepatic Failure Associated with Imipramine Therapy

Shaefer, M. S., Edmunds, A. L., Markin, R. S., Wood, R. P., Pillen, T. J., & Shaw, B. W. (1990) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1990.tb02551.x · Cited by 19 · see citing works

Intrahepatic cholestasis associated with moclobemide leading to death

Timmings, P. L., & Lamont, D. L. (1996) · The Lancet · doi:10.1016/s0140-6736(96)90114-2 · Cited by 18 · see citing works

Acute Liver Failure with Concurrent Bupropion and Carbimazole Therapy

Khoo, A.-L., Tham, L., Lee, K.-H., & Gek-Kee, L. (2003) · Annals of Pharmacotherapy · doi:10.1177/106002800303700212 · Cited by 18 · see citing works

Jaundice and eosinophilia associated with amitriptyline.

Bn, A., & Ir, H. (1978) · PubMed · Cited by 18 · see citing works

Nortriptyline-Induced Hepatic Failure

Pedersen, A.-M. B., & Enevoldsen, H. K. (1996) · Therapeutic Drug Monitoring · doi:10.1097/00007691-199602000-00017 · Cited by 17 · see citing works

Amineptine induced liver injury. Report of two cases and brief review of the literature.

Lazaros, G. A., Stavrinos, C., Papatheodoridis, G., Delladetsima, J. K., Toliopoulos, A., & Tassopoulos, N. (1996) · PubMed · Cited by 16 · see citing works

Hepatotoxicity of Citalopram in Rats and First-Pass Metabolism

Overø, K. F., & Svendsen, O. (1978) · Archives of toxicology. Supplement · doi:10.1007/978-3-642-66896-8_25 · Cited by 16 · see citing works

[Acute hepatitis during treatment with fluoxetine].

Mars, F., Roque, G. D. D. L., & Goissen, P. (1991) · PubMed · Cited by 14 · see citing works

A Study of Blood Count and Serum Transaminase in Prolonged Treatment with Amitriptyline

Holmberg, M. B., & Jansson, B. (1962) · The Journal of New Drugs · doi:10.1177/009127006200200606 · Cited by 14 · see citing works

Desipramine-associated hepatitis.

Lh, P., Jc, N., & Waltrip, R. W. (1983) · PubMed · Cited by 13 · see citing works

Concurrent Agranulocytosis and Hepatitis Secondary to Clomipramine Therapy

Alderman, C. P., Atchison, M., & McNeece, J. I. (1993) · The British Journal of Psychiatry · doi:10.1192/bjp.162.5.688 · Cited by 13 · see citing works

Hepatitis aguda por ticlopidina. Presentación de 12 casos y revisión de la literatura

Pizarro, Á. E., Andrade, R. J., García‐Cortés, M., Lucena, M. I., Moreno, J. M. P., Montenegro, M. P., Sanchez-Martinez, H., Álvarez, J. L. M., Durán, J. A., Saenz, M. J., et al. (2001) · Revista de Neurología · doi:10.33588/rn.3311.2001285 · Cited by 13 · see citing works

Clotiazepam-induced acute hepatitis

Habersetzer, F., Larrey, D. G., Babany, G., Degott, C., Corbic, M., Pessayre, D., & Benhamou, J. (1989) · Journal of Hepatology · doi:10.1016/0168-8278(89)90060-3 · Cited by 12 · see citing works

MORPHOLOGICAL AND BIOCHEMICAL ALTERATION IN THE RAT LIVER INDUCED BY MAPROTILINE

Tanaka, H., Watanabe, M., Hattori, Y., Furusato, M., & Takasaki, S. (1975) · Acta Pathologica Japonica · doi:10.1111/j.1440-1827.1975.tb00863.x · Cited by 12 · see citing works

Acute Fulminant Hepatitis After Treatment With Rabeprazole and Terbinafine: Is Rabeprazole the Culprit?

Andrade, R. J., & Lucena, M. I. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.3.360 · Cited by 10 · see citing works

Doxepin‐induced recurrent acute hepatitis

Keegan, A. D. (1993) · Australian and New Zealand Journal of Medicine · doi:10.1111/j.1445-5994.1993.tb01843.x · Cited by 10 · see citing works

Case Report of Hepatotoxicity Associated with Maprotiline

Weinstein, R. P., & Gosselin, J. Y. (1988) · The Canadian Journal of Psychiatry · doi:10.1177/070674378803300314 · Cited by 10 · see citing works

[Acute hepatitis during treatment with fluoxetine].

Bobichon, R., Bernard, G., & Mion, F. (1993) · PubMed · Cited by 10 · see citing works

[Severe hepatitis attributed to paroxetine (Seroxat)].

de Man, R. A. (1997) · PubMed · Cited by 9 · see citing works

Hepatitis Caused by Antidepressive Therapy with Maprotiline and Opipramol

Braun, J. M., Geiger, R., Wehner, H., Schäffer, S., & Berger, T. (1998) · Pharmacopsychiatry · doi:10.1055/s-2007-979319 · Cited by 9 · see citing works

Withdrawal of nomifensine.

Morton, A. R., Yu, R., Waldek, S., Holmes, A. M., & Mundy, K. (1986) · BMJ · doi:10.1136/bmj.293.6544.452-b · Cited by 9 · see citing works

Hepatic Failure Associated with Imipramine Therapy

Ilan, Y., Samuel, D., REYNES, M., & Tur‐Kaspa, R. (1996) · Pharmacopsychiatry · doi:10.1055/s-2007-979549 · Cited by 9 · see citing works

A prospective evaluation of the hepatotoxicity of lofepramine in the elderly

Kelly, C., Roche, S., Naguib, M., Webb, S. F., Roberts, M., & Pitt, B. (1993) · International Clinical Psychopharmacology · doi:10.1097/00004850-199300820-00001 · Cited by 9 · see citing works

[Hepatotoxicity of mianserin: a case with positive reintroduction].

Jc, B., Biour, M., Cadot, T., & Jp, L. (1992) · PubMed · Cited by 9 · see citing works

Treatment of Acute Mania with Verapamil

Patterson, J. F. (1987) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-198706000-00035 · Cited by 8 · see citing works

[Hepatitis probably secondary to the massive ingestion of fluvoxamine].

Ks, L., Blanchi, A., & Jm, C. (1988) · PubMed · Cited by 8 · see citing works

[Behavioral disorders after treatment with isoniazid].

Djibo, A., & Lawan, A. (2001) · PubMed · Cited by 8 · see citing works

Hepatotoxicity associated with maprotiline therapy: case report.

Moldawsky, R. J. (1984) · PubMed · Cited by 7 · see citing works

Acute Liver Failure with Concurrent Bupropion and Carbimazole Therapy

Khoo, A.-L., Tham, L., Lee, K.-H., & Gek-Kee, L. (2003) · Annals of Pharmacotherapy · doi:10.1345/aph.1c159 · Cited by 7 · see citing works

Hepatotoxicity Following Treatment with Maprotiline

Aleem, A., & Lingam, V. (1987) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-198702000-00028 · Cited by 6 · see citing works

[Acute mixed hepatitis caused by tianeptine].

Balleyguier, C., Stérin, D., Ziol, M., & Jc, T. (1996) · PubMed · Cited by 6 · see citing works

[Hepatitis due to amineptin. 4 cases].

Andrieu, J., Doll, J., & Coffinier, C. (1982) · PubMed · Cited by 6 · see citing works

[Hepatitis and amineptin].

Martin, D., Pm, B., Martin, C., Moene, Y., & Ducret, F. (1981) · PubMed · Cited by 5 · see citing works

Depression

Glass, R. M. (2002) · JAMA · doi:10.1001/jama.288.11.1400 · Cited by 4 · see citing works

[Acute cytolytic hepatitis caused by amoxapine].

Manapany, M., Marchetti, B., Bertrand-Lepensec, D., Lacroix, G., & Legré, M. (1993) · PubMed · Cited by 4 · see citing works

[Fever and liver function disorders caused by nomifensine (Alival)].

Dankbaar, H., & Mudde, A. H. (1980) · PubMed · Cited by 4 · see citing works

[Acute liver necrosis after treatment with opipramol].

van Vliet, A. C., Frenkel, M. P. C., & Jh, W. (1977) · PubMed · Cited by 4 · see citing works

Hepatic injury associated with amineptine therapy.

Rosellini, S. R., Grilli, F., Gaudio, M., Saragoni, A., & Miglio, F. (1990) · PubMed · Cited by 4 · see citing works

Amoxapine Associated with Hepatotoxicity

John, F. P. (1987) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-198702000-00024 · Cited by 3 · see citing works

[Acute benign hepatitis probably due to maprotiline].

Prudent, A., Marchetti, B., Pignol, D., Lacroix, G., Bouckson, G., & Legré, M. (1988) · PubMed · Cited by 3 · see citing works

[Auxiliary hepatic transplantation in iproniazid-induced subfulminant hepatitis. Should iproniazid still be sold in France?].

Maille, F., Duvoux, C., Cherqui, D., Radier, C., Zafrani, É. S., & Dhumeaux, D. (1999) · PubMed · Cited by 3 · see citing works

Un «mundo feliz»

Carné, X., & Massana, J. (2001) · Medicina Clínica · doi:10.1016/s0025-7753(01)71819-2 · Cited by 2 · see citing works

[Immediate acute hepatic cytolysis after the administration of a single amineptin tablet].

Jonville, A. P., Dutertre, J.-P., & AUTRET, E. (1992) · PubMed · Cited by 1 · see citing works

[Chronic cirrhogenic hepatitis caused by amineptin (Survector)?].

Imbert, Y., Ducos, P., Grière, G., Sanson, & Dupont, E. (1985) · PubMed · Cited by 1 · see citing works

RUCAM in Drug and Herb Induced Liver Injury: The Update

Danan, G., & Teschke, R. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms17010014 · Cited by 818 · see citing works

DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans

Chen, M., Suzuki, A., Thakkar, S., Yu, K., Hu, C., & Tong, W. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2016.02.015 · Cited by 398 · see citing works

Risk Factors for Idiosyncratic Drug-Induced Liver Injury

Chalasani, N., & Björnsson, E. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.04.001 · Cited by 347 · see citing works

Addressing the Side Effects of Contemporary Antidepressant Drugs: A Comprehensive Review

Wang, S.-M., Han, C., Bahk, W.-M., Lee, S.-J., Patkar, A. A., Masand, P. S., & Pae, C.-U. (2018) · Chonnam Medical Journal · doi:10.4068/cmj.2018.54.2.101 · Cited by 299 · see citing works

A treatment algorithm for neuropathic pain

Namaka, M., Gramlich, C., Ruhlen, D., Melanson, M., Sutton, I., & Major, J. (2004) · Clinical Therapeutics · doi:10.1016/s0149-2918(04)90171-3 · Cited by 138 · see citing works

Drug-induced liver injury: Is it somehow foreseeable?

Tarantino, G., Minno, M. N. D. D., & Capone, D. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.2817 · Cited by 137 · see citing works

Investigating Drug-induced Mitochondrial Toxicity: A Biosensor to Increase Drug Safety?

Pereira, C., Moreira, A. C., Pereira, S. P., Machado, N. J., Carvalho, F. S., Sardão, V. A., & Oliveira, P. J. (2009) · Current Drug Safety · doi:10.2174/157488609787354440 · Cited by 105 · see citing works

Recurrent Drug-Induced Liver Injury (DILI) with different drugs in the Spanish Registry: The dilemma of the relationship to autoimmune hepatitis

Lucena, M. I., Kaplowitz, N., Hallal, H., Castiella, A., García–Bengoechea, M., Otazua, P., Berenguer, M., Fernández‐Santaella, M. C., Planas, R., & Andrade, R. J. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2010.12.041 · Cited by 105 · see citing works

Antidepressant medications and other treatments of depressive disorders: a CINP Task Force report based on a review of evidence

Sartorius, N., Baghai, T. C., Baldwin, D. S., Barrett, B. M., Brand, U., Fleischhacker, W., Goodwin, G. M., Grunze, H., Knapp, M. R. J., Leonard, B. E., et al. (2007) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145707008255 · Cited by 98 · see citing works

Drug-Induced Liver Injury: Insights from Genetic Studies

Andrade, R. J., Robles‐Díaz, M., Ulzurrun, E., & Lucena, M. I. (2009) · Pharmacogenomics · doi:10.2217/pgs.09.111 · Cited by 94 · see citing works

Antidepressant-lnduced Liver Injury

DeSanty, K. P., & Amabile, C. M. (2007) · Annals of Pharmacotherapy · doi:10.1345/aph.1k114 · Cited by 84 · see citing works

Assessment of drug‐induced liver injury in clinical practice

Lucena, M. I., García‐Cortés, M., Cueto-Galán, R., Lopez‐Duran, J., & Andrade, R. J. (2008) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.2008.00566.x · Cited by 78 · see citing works

Metabolic bioactivation and drug-related adverse effects: current status and future directions from a pharmaceutical research perspective

Tang, W., & Lu, A. Y. H. (2009) · Drug Metabolism Reviews · doi:10.3109/03602530903401658 · Cited by 77 · see citing works

Chronic administration of fluoxetine or clozapine induces oxidative stress in rat liver: A histopathological study

Martinović, J., Todorović, N., Tomanović, N., Bošković, M., Djordjević, S., Pašti, T. D. L., Bernardi, R. E., Djurdjevic, A., & Filipović, D. (2014) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2014.04.010 · Cited by 73 · see citing works

Causality assessment in drug-induced hepatotoxicity

Andrade, R. J., Camargo, R., Lucena, M. I., & González‐Grande, R. (2004) · Expert Opinion on Drug Safety · doi:10.1517/14740338.3.4.329 · Cited by 71 · see citing works

Monitoring for antidepressant-associated adverse events in the treatment of patients with major depressive disorder: An international consensus statement

Dodd, S., Mitchell, P. B., Bauer, M., Yatham, L. N., Young, A. H., Kennedy, S. H., Williams, L. J., Suppes, T. M., López‐Jaramillo, C., Trivedi, M. H., et al. (2017) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2017.1379609 · Cited by 66 · see citing works

Rechallenge in drug-induced liver injury: the attractive hazard

Andrade, R. J., Robles‐Díaz, M., & Lucena, M. I. (2009) · Expert Opinion on Drug Safety · doi:10.1517/14740330903397378 · Cited by 54 · see citing works

A 1H-NMR-Based Metabonomic Study on the Anti-Depressive Effect of the Total Alkaloid of Corydalis Rhizoma

Wu, H., Wang, P., Liu, M., Tang, L., Fang, J., Zhao, Y., Zhang, Y., Li, D., Xu, H., & Yang, H. (2015) · Molecules · doi:10.3390/molecules200610047 · Cited by 52 · see citing works

Antidepressant-like effects of a cocoa polyphenolic extract in Wistar–Unilever rats

Messaoudi, M., Bisson, J., Nejdi, A., Rozan, P., & Javelot, H. (2008) · Nutritional Neuroscience · doi:10.1179/147683008x344165 · Cited by 52 · see citing works

The Effect of Chronic Mild Stress and Imipramine on the Markers of Oxidative Stress and Antioxidant System in Rat Liver

Duda, W., Curzytek, K., Kubera, M., Iciek, M., Kowalczyk‐Pachel, D., Bilska‐Wilkosz, A., Lorenc‐Koci, E., Leśkiewicz, M., Basta‐Kaim, A., Budziszewska, B., et al. (2016) · Neurotoxicity Research · doi:10.1007/s12640-016-9614-8 · Cited by 52 · see citing works

Mechanism-based bioanalysis and biomarkers for hepatic chemical stress

Antoine, D. J., Mercer, A. E., Williams, D. P., & Park, B. K. (2009) · Xenobiotica · doi:10.1080/00498250903046993 · Cited by 49 · see citing works

Metabolomics analysis of the antidepressant prescription Danzhi Xiaoyao Powder in a rat model of Chronic Unpredictable Mild Stress (CUMS)

Zhu, Y., Li, S.-L., Zhu, C., Wang, W., Zuo, W.-F., & Qiu, X. (2020) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2020.112832 · Cited by 49 · see citing works

A Consensus Statement for Safety Monitoring Guidelines of Treatments for Major Depressive Disorder

Dodd, S., Malhi, G. S., Tiller, J. W. G., Schweitzer, I., Hickie, I. B., Khoo, J., Bassett, D. L., Lyndon, B., Mitchell, P. B., Parker, G. B., et al. (2011) · Australian & New Zealand Journal of Psychiatry · doi:10.3109/00048674.2011.595686 · Cited by 44 · see citing works

Case Report: Fulminant Hepatic Failure Involving Duloxetine Hydrochloride

Hanje, A. J., Pell, L. J., Votolato, N. A., Frankel, W. L., & Kirkpatrick, R. B. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.04.018 · Cited by 42 · see citing works

Post-traumatic stress disorder: an evaluation of existing pharmacotherapies and new strategies

Zhang, W., & Davidson, J. R. T. (2007) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.8.12.1861 · Cited by 40 · see citing works

Sertraline hepatotoxicity: Report of a case and review of the literature

Collados, V., Hallal, H., & Andrade, R. J. (2010) · Digestive Diseases and Sciences · doi:10.1007/s10620-010-1192-7 · Cited by 33 · see citing works

Hepatotoxicity Related to Agomelatine and Other New Antidepressants: A Case/Noncase Approach With Information From the Portuguese, French, Spanish, and Italian Pharmacovigilance Systems

Montastruc, F., Scotto, S., Vaz, I. R., Guerra, L. N., Escudero, A., Sáinz, M., Falomir, T., Bagheri, H., Herdeiro, M. T., Venegoni, M., et al. (2014) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000094 · Cited by 33 · see citing works

A New Structure-Activity Relationship (SAR) Model for Predicting Drug-Induced Liver Injury, Based on Statistical and Expert-Based Structural Alerts

Pizzo, F., Lombardo, A., Manganaro, A., & Benfenati, E. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00442 · Cited by 33 · see citing works

Which psychotropic medications induce hepatotoxicity?

Sedky, K., Nazir, R., Joshi, A., Kaur, G., & Lippmann, S. (2011) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2011.10.007 · Cited by 30 · see citing works

Evaluation of the antidepressant- and anxiolytic-like effects of a hydrophilic extract from the green seaweed Ulva sp. in rats

Violle, N., Rozan, P., Demais, H., Collén, P. N., & Bisson, J. (2017) · Nutritional Neuroscience · doi:10.1080/1028415x.2016.1276704 · Cited by 29 · see citing works

Bupleurum in Treatment of Depression Disorder: A Comprehensive Review

Ran, S., Peng, R., Guo, Q., Cui, J., Chen, G., & Wang, Z. (2024) · Pharmaceuticals · doi:10.3390/ph17040512 · Cited by 26 · see citing works

Mechanisms of paeoniaceae action as an antidepressant

Guo, W., Yao, X.-X., Cui, R., Yang, W., & Wang, L. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.934199 · Cited by 27 · see citing works

Include mushroom in daily diet—A strategy for better hepatic health

Chatterjee, A., & Acharya, K. (2015) · Food Reviews International · doi:10.1080/87559129.2015.1057839 · Cited by 25 · see citing works

Negative impact of comorbidities on all-cause mortality of patients with psoriasis is partially alleviated by biologic treatment: A real-world case-control study

Riaz, S., Emam, S., Wang, T., & Gniadecki, R. (2024) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2024.01.078 · Cited by 22 · see citing works

Causality Assessment Methods in Drug-Induced Liver Injury

Teschke, R., & Danan, G. (2018) · Methods in pharmacology and toxicology · doi:10.1007/978-1-4939-7677-5_27 · Cited by 22 · see citing works

Idiosyncratic drug hepatotoxicity: a 2008 update

Andrade, R. J., López-Ortega, S., López‐Vega, M. C., Robles‐Díaz, M., Cueto, I., & Lucena, M. I. (2008) · Expert Review of Clinical Pharmacology · doi:10.1586/17512433.1.2.261 · Cited by 22 · see citing works

Metabolic bioactivation of antidepressants: advance and underlying hepatotoxicity

Khalil, S. M., MacKenzie, K. R., Maletić‐Savatić, M., & Li, F. (2024) · Drug Metabolism Reviews · doi:10.1080/03602532.2024.2313967 · Cited by 20 · see citing works

Camellia euphlebia exerts its antidepressant-like effect via modulation of the hypothalamic-pituitary-adrenal axis and brain monoaminergic systems

He, D., Sai, X., Wang, N., Li, X., Wang, L., & Xu, Y. (2017) · Metabolic Brain Disease · doi:10.1007/s11011-017-0167-1 · Cited by 18 · see citing works

Causal relationship between depression and metabolic dysfunction-associated steatotic liver disease: a bidirectional Mendelian randomized study

Liang, W., Zhong, K., Lai, T., Zeng, Y., Huang, Z., Zhou, J., Huang, J., Shi, Z., Zhang, J., & Ding, F. (2024) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2024.1384003 · Cited by 16 · see citing works

Adverse reactions and their mechanisms from nimesulide

Bjarnason, I., Bissoli, F., Conforti, A., Maiden, L., Moore, N. D., Moretti, U., Rainsford, K. D., Takeuchi, K., & Velo, G. P. (2005) · Birkhäuser Basel eBooks · doi:10.1007/3-7643-7410-1_6 · Cited by 15 · see citing works

A case report of a drug‐induced liver injury (DILI) caused by multiple antidepressants with causality established by the updated Roussel Uclaf causality assessment method (RUCAM) and in vitro testing

González‐Muñoz, M., Villatoro, J. M., Marín‐Serrano, E., Stewart, S. M., Rivera, B. B., Marín, J., de Soto, L. M., Seco-Meseguer, E., & Ramı́rez, E. (2020) · Clinical Case Reports · doi:10.1002/ccr3.3348 · Cited by 15 · see citing works

Drug‐Induced Liver Injury Associated With Antidepressive Psychopharmacotherapy: An Explorative Assessment Based on Quantitative Signal Detection Using Different MedDRA Terms

Gahr, M., Zeiss, R., Lang, D., Connemann, B. J., Hiemke, C., & Schönfeldt‐Lecuona, C. (2015) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.662 · Cited by 14 · see citing works

Medical Management of Depression

Malani, A. K., & Ammar, H. (2006) · New England Journal of Medicine · doi:10.1056/nejmc053231 · Cited by 14 · see citing works

Tricyclic antidepressants induce liver inflammation by targeting NLRP3 inflammasome activation

Mu, W., Xu, G., Wang, Z., Li, Q., Sun, S., Qin, Q., Li, Z., Shi, W., Dai, W., Zhan, X., et al. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-023-01128-x · Cited by 13 · see citing works

Risk Factors for Drug-Induced Liver Disease

Vuppalanchi, R., & Chalasani, N. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-387817-5.00016-9 · Cited by 12 · see citing works

Mitochondrial Targeting for Drug Development

Pourahmad, J., Salimi, A., & Seydi, E. (2015) · InTech eBooks · doi:10.5772/59719 · Cited by 12 · see citing works

Mechanisms of hepatocellular toxicity associated with the components of St. John’s Wort extract hypericin and hyperforin in HepG2 and HepaRG cells

Abegg, V. F., Panajatovic, M. V., Mancuso, R. V., Allard, J. A., Duthaler, U., Odermatt, A., Krähenbühl, S., & Bouitbir, J. (2024) · Toxicology Letters · doi:10.1016/j.toxlet.2024.01.008 · Cited by 10 · see citing works

Drug-Induced Liver Disease Related to Citalopram

Neumann, H., Csepregi, A., Evert, M., & Malfertheiner, P. (2008) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e318167b8e1 · Cited by 10 · see citing works

High-Dose Ziprasidone Monotherapy in Bipolar I Disorder Patients With Depressed or Mixed Episodes

Mech, A. W. (2008) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31816745de · Cited by 10 · see citing works

Hepatotoxicidad asociada a sertralina

Collados Arroyo, V., Plaza Aniorte, J., Hallal, H., & Pérez-Cuadrado, E. (2008) · Farmacia Hospitalaria · doi:10.1016/s1130-6343(08)72814-9 · Cited by 9 · see citing works

Monoamine Oxidases and Flavin-Containing Monooxygenases

Cashman, J. R., & Motika, M. S. (2010) · Elsevier eBooks · doi:10.1016/b978-0-08-046884-6.00405-x · Cited by 9 · see citing works

Cholestatic Jaundice Induced by Duloxetine in a Patient with Major Depressive Disorder

Park, Y. M., Lee, B.-H., Lee, H., & Kang, S. (2010) · Psychiatry Investigation · doi:10.4306/pi.2010.7.3.228 · Cited by 9 · see citing works

Extended-release quetiapine fumarate in the treatment of patients with major depressive disorder: adjunct therapy

Weisler, R. H., McIntyre, R. S., & Bauer, M. (2013) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2013.846519 · Cited by 7 · see citing works

Clinical preference for factors in treatment of geriatric depression

Riepe, M. W. (2014) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s75450 · Cited by 6 · see citing works

Monoamine Oxidases and Flavin-Containing Monooxygenases

Cashman, J. R. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.64091-6 · Cited by 6 · see citing works

Drug-Induced Liver Injury

Donepudi, I., Massoumi, H., Dharmarajan, T. S., Dharmarajan, T. S., Dharmarajan, T. S., Dharmarajan, T. S., Pitchumoni, C. S., Pitchumoni, C. S., & Pitchumoni, C. S. (2012) · Springer eBooks · doi:10.1007/978-1-4419-1623-5_41 · Cited by 3 · see citing works

A strategy to improve the detection of drug-induced hepatotoxicity

Montero, A., Quintana, J. A. D., Sáenz, M. J., & Delgado, J. (2005) · Revista Española de Enfermedades Digestivas · doi:10.4321/s1130-01082005000300003 · Cited by 4 · see citing works

Crocin lessens desipramine-induced phospholipidosis biomarker levels via targeting oxidative stress- related PI3K/Akt/mTOR signaling pathways in the rat liver.

El-Sheikh, A. A., Mahmoud, H. A., Elkordy, E. A., Abdelsattar, A. M., Rizk, F. H., Elsharaby, R. M., Mashal, S. S., Saadany, A. A. E., Shalaby, R. H., Elshamy, A. M., et al. (2023) · Acta bio-medica dell'Ateneo parmense/Acta biomedica · doi:10.23750/abm.v94i2.14442 · Cited by 3 · see citing works

Monoamine oxidase inhibitors for treatment-resistant depression

Bobo, W. V., & Richelson, E. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-824067-0.00009-8 · Cited by 3 · see citing works

Chapter 2 Drug-Induced Hepatotoxicity: Learning from Recent Cases of Drug Attrition

Pähler, A., & Funk, C. (2008) · Advances in molecular toxicology · doi:10.1016/s1872-0854(07)02002-4 · Cited by 2 · see citing works

The Effects of Acupuncture on Insomnia, Anxiety, and Depression in Women with Chronic Liver Disease: A Randomized Controlled Trial

Kwak, S. M. K. M. A. (2015) · Alternative & Integrative Medicine · doi:10.4172/2327-5162.1000194 · Cited by 2 · see citing works

HEPATITIS TOXICA - CASE REPORT

Radović, J., Popović, L., Đorđević, J., Jovanović, B., Trifunović, G., Đorđević, M., & Kostić, V. (2009) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 2 · see citing works

Acute Drug-Induced Hepatitis Associated With Vortioxetine: A Case Report

Guimarães, C., Ribeiro, R., Reis, H. H., Ribeiro, M., & Almeida, J. S. (2025) · Cureus · doi:10.7759/cureus.98067 · Cited by 1 · see citing works

Hepatitis colestásica por venlafaxina

Arroyo, V. C., Hallal, H., Agudo, J. L. R., & Aniorte, J. P. (2009) · Gastroenterología y Hepatología · doi:10.1016/j.gastrohep.2008.11.012 · Cited by 1 · see citing works

Depressive Disorders: Major Depressive Disorder and Persistent Depressive Disorder

MacKinnon, D. F. (2015) · Wiley eBooks · doi:10.1002/9781118753378.ch50 · Cited by 1 · see citing works

Agents and drugs: precautions in patients with cirrhosis

Stickel, F. (2015) · doi:10.1002/9781118412640.ch23 · Cited by 1 · see citing works

Impact of antidepressant drug clomipramine on hepatorenal functions, lipid peroxidation, micronucleus frequencies and DNA damage using an alkaline comet assay

Agha, F. E., Youness, E. R., & Hassanane, M. M. (2013) · Journal of Experimental and Applied Animal Sciences · doi:10.20454/jeaas.2013.713

Liver disorders

Lloyd, G. (2007) · Cambridge University Press eBooks · doi:10.1017/cbo9780511543975.018

Hepatitis tóxica por antidepresivos

Barbón, S. R., Durán, D. L., & Miranda, E. (2008) · Gastroenterología y Hepatología · doi:10.1157/13114570

Role of Antidepressants in the Management of Pain

Waldman, S. D. (2007) · Elsevier eBooks · doi:10.1016/b978-0-7216-0334-6.50118-7

PRIVATE ISSUES OF HEPATOTOXICITY OF PSYCHOTROPIC DRUGS

V., O. V. K. O., Smirnova, E. N., & Komarovskaya, N. L. (2018) · Экспериментальная и клиническая гастроэнтерология · doi:10.31146/1682-8658-ecg-156-8-125-131

Current awareness in human psychopharmacology

(2003) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.461

Current awareness: Pharmacoepidemiology and drug safety

(2003) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.792

Role of Antidepressants in the Management of Pain

Waldman, S. D., & Waldman, C. W. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0721-2.00123-9

Music Medicine for Neurological Disorders

Chauhan, N. B., Kale, M., Gujar-Kale, P., Desai, M., Jain, D. K., & Iyer, A. (2024) · Integrated science · doi:10.1007/978-3-031-73061-0_26

Early prediction of potential hepatotoxic metabolites to aid lead selection in drug discovery

Chiappalupi, L., Gargallo‐Viola, D., & Torrens, A. (2025) · Open Research Europe · doi:10.12688/openreseurope.21392.1

Additional file 2 of Tricyclic antidepressants induce liver inflammation by targeting NLRP3 inflammasome activation

Mu, W., Xu, G., Wang, Z., Li, Q., Sun, S., Qin, Q., Li, Z., Shi, W., Dai, W., Zhan, X., et al. (2023) · Figshare · doi:10.6084/m9.figshare.23208018

Additional file 1 of Tricyclic antidepressants induce liver inflammation by targeting NLRP3 inflammasome activation

Mu, W., Xu, G., Wang, Z., Li, Q., Sun, S., Qin, Q., Li, Z., Shi, W., Dai, W., Zhan, X., et al. (2023) · Figshare · doi:10.6084/m9.figshare.23208012

Antidepressant-lnduced Liver Injury

DeSanty, K. P., & Amabile, C. M. (2007) · Annals of Pharmacotherapy · doi:10.1345/aph.1k114 · Cited by 84 · see citing works

Biochemical and Molecular Mechanisms of Liver Damage-Induced by Antidepressant Drugs: an Update Review

Pal, A., & Roy, D. N. (2017) · Current Hepatology Reports · doi:10.1007/s11901-017-0366-6 · Cited by 6 · see citing works

Antidepressant-Induced Liver Injury: A Review for Clinicians

Voican, C. S., Corruble, E., Naveau, S., & Perlemuter, G. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2013.13050709 · Cited by 277 · see citing works

Liver Injury Associated with Antidepressants

Park, S. J., & Ishino, R. (2013) · Current Drug Safety · doi:10.2174/1574886311308030011 · Cited by 67 · see citing works

Hepatotoxicity of Antidepressants

DAVIS, M. (1991) · International Clinical Psychopharmacology · doi:10.1097/00004850-199100620-00004 · Cited by 12 · see citing works